Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Brought to you by

Tengion completes its IPO

27 Apr 2012

Executive Summary

Four months after filing, Tengion Inc. (regenerative medicine) has netted $28mm through its initial public offering of 6mm common shares at $5 each. The company had originally hoped to bring in $46mm, but then lowered its expectations to $41mm. Just last month it said it would sell 4.44mm shares for up to $10 apiece.
Deal Industry
  • Pharmaceuticals
  • Medical Devices
    • Implantable Devices
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By